

Neural tube defects. Results of long-term epidemiological observation in the regions of the Russian Federation
https://doi.org/10.25557/2073-7998.2025.07.15-23
Abstract
Introduction. Neural tube defects (NTDs), being frequent and severe developmental defects, remain a significant cause of mortality and morbidity in newborns, and make a significant contribution to the structure of stillbirth causes. To plan the volumes and implement preventive measures aimed at reducing the level of NTDs, it is important to know the epidemiological characteristics of defects in the regions of the Russian Federation.
Aim: to estimate the frequency of neural tube defects in the regions of the Russian Federation based on monitoring of congenital defects.
Methods. The study included a retrospective analysis of the database of epidemiological monitoring of congenital malformations (CM), covering a 13-year period (2011-2023). The material was data from 33 regions of the Russian Federation that regularly monitor CM. The study included cases of defects among live births, stillbirths, as well as eliminated fetuses with NTDs.
Results. During the analyzed period, 7989 cases of NTDs were registered in the congenital malformations monitoring database, the total number of newborns was 6,834,020. The total incidence of NTDs was 11.69 per 10,000 births (95% CI 11.56-11.82). Among all cases of NTDs, live births accounted for 22.32%, stillbirths – 4.03%, and eliminated fetuses – 73.65%. Regional frequencies ranged from 3.25 to 19.99 per 10,000 births. In the NTD group, the most common defect is spinal bifida, while encephalocele is a rare defect. During the study period, the level of NTDs in all regions remains stable, however, in recent years (2020-2023) there has been a slight decrease in the level of NTDs, which is due to secondary prevention measures.
Conclusions. NTDs remain common congenital malformations. During the analyzed period, the frequency of this group of defects remains stable. The observed decrease in the level of NTDs among newborns is the result of second-level preventive measures. Obviously, in order to reduce the overall incidence of NTDs, it is necessary to increase the effectiveness of primary prevention (raising awareness of women of reproductive age about the possibilities of reducing risks, timely intake of folic acid).
About the Authors
N. S. DemikovaRussian Federation
2, Taldomskya st., Moscow, 125412;
2/1, Barrikadnaya st., Moscow, 125993
A. N. Putintsev
Russian Federation
2, Taldomskya st., Moscow, 125412
D. A. Nikolsky
Russian Federation
2, Taldomskya st., Moscow, 125412
A. Yu. Asanov
Russian Federation
8-2, Trubetskaya st.. Moscow, 119991
References
1. Atlaw D., Tekalegn Y., Sahiledengle B., et al. Magnitude and determinants of neural tube defect in Africa: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2021;21(1):426. https://doi.org/10.1186/s12884-021-03848-9.
2. Suarez L., Felkner M., Brender J.D., et al. Maternal exposures to cigarette smoke, alcohol, and street drugs and neural tube defect occurrence in offspring. Matern Child Health J. 2008;12(3):394– 401. https://doi.org/10.1007/s10995-007-0251-y.
3. Christianson A., Howson C.P., Modell B. March of Dimes: global report on birth defects, the hidden toll of dying and disabled children. 2005. https://www.MarchofDimes.org/global-report on birth defects the hidden toll of dying and disabled children.
4. Li Z., Ren A., Zhang L., et al. Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China. Birth Defects Res A Clin Mol Teratol. 2006; 76: 237-240.
5. Jacobsen P. Regional variations in neural tube defects and alfafetoprotein screening in Denmark 1983-88. Acta Obstet Gynecol Scand. 1996; 75: 620-623.
6. De Wals P., Rusen I.D., Lee N.S., Morin P., Niyonsenga T. Trend in prevalence of neural tube defects in Quebec. Birth Defects Res A Clin Mol Teratol. 2003; 67: 919-923. 7. https://eu-rd-platform.jrc.ec.europa.eu/eurocat/eurocat-data/prevalence_en
7. Lempinen J., Koskimies-Virta E., Kauppala T., et al. Epidemiology of neural tube defects in Finland: a nationwide register study 1987- 2018. Int J Epidemiol. 2024;53(4):dyae092. doi: 10.1093/ije/dyae092.
8. Alembik Y., Dott B., Roth M.P., Stoll C. Prevalence of neural tube defects in northeastern France, 1979-1992 impact of prenatal diagnosis. Ann Genet. 1995; 38: 49-53.
9. Rankin J., Glinianaia S., Brown R., Renwick M. The changing prevalence of neural tube defects: a population-based study in the north of England, 1984-96. Northern Congenital Abnormality Survey Steering Group. Paediatr Perinat Epidemiol. 2000; 14: 104-110.
10. Samson G.R. The Incidence and Demographic of Neural Tube Defects in Abu Dhabi, United Arab Emirates (1992-1999). J Trop Pediatr. 2003; 49: 256-257.
11. Rajab A., Vaishnav A., Freeman N.V., Patton M.A. Neural tube defects and congenital hydrocephalus in the Sultanate of Oman. J Trop Pediatr. 1998; 44: 300-303.
12. Teebi A.S., al Saleh Q.A., Odeh H. Meckel syndrome and neural tube defects in Kuwait. J Med Genet. 1992; 29: 140.
13. Hendricks K.A., Simpson J.S., Larsen R.D. Neural tube defects along the Texas-Mexico border, 1993-1995. Am J Epidemiol. 1999; 149: 1119-1127.
14. Li Z., Ren A., Zhang L., et al. Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China. Birth Defects Res A Clin Mol Teratol. 2006; 76: 237-240.
15. Zaganjor I., Sekkarie A., Tsang B.L., et al. Describing the Prevalence of Neural Tube Defects Worldwide: A Systematic Literature Review. PLoS One. 2016;11(4):e0151586. doi: 10.1371/journal.pone.0151586.
16. Kancherla V. Neural tube defects: a review of global prevalence, causes, and primary prevention. Childs Nerv Syst. 2023; 39 (7): 1703–1710. https://doi.org/10.1007/s00381-023-05910-7.
17. Çaylan N., Yalçin S.S., Tezel B., et al. Evaluation of neural tube defects from 2014 to 2019 in Turkey. BMC Pregnancy Childbirth. 2022;22(1):340. doi: 10.1186/s12884-022-04678-z.
Review
For citations:
Demikova N.S., Putintsev A.N., Nikolsky D.A., Asanov A.Yu. Neural tube defects. Results of long-term epidemiological observation in the regions of the Russian Federation. Medical Genetics. 2025;24(7):15-23. (In Russ.) https://doi.org/10.25557/2073-7998.2025.07.15-23